BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25282406)

  • 1. 'Organised' cervical screening 45 years on: How consistent are organised screening practices?
    Williams JH; Carter SM; Rychetnik L
    Eur J Cancer; 2014 Nov; 50(17):3029-38. PubMed ID: 25282406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.
    Nowakowski A; Cybulski M; Śliwczyński A; Chil A; Teter Z; Seroczyński P; Arbyn M; Anttila A
    BMC Cancer; 2015 Apr; 15():279. PubMed ID: 25879466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical cancer screening: A Slovenian experience.
    Primic-Zakelj M; Repse-Fokter A
    Coll Antropol; 2007 Apr; 31 Suppl 2():23-6. PubMed ID: 17600934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cancer screening. Organised screening to avoid unnecessary conisation.
    Prescrire Int; 2010 Aug; 19(108):172-7, 179. PubMed ID: 20939454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening for cervical cancer in the county of Funen. Status of 25 years of development and experiences].
    Hølund B; Grinsted P
    Ugeskr Laeger; 2006 May; 168(22):2163-6. PubMed ID: 16768956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cancer screening in Europe: Quality assurance and organisation of programmes.
    Elfström KM; Arnheim-Dahlström L; von Karsa L; Dillner J
    Eur J Cancer; 2015 May; 51(8):950-68. PubMed ID: 25817010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
    Sankaranarayanan R; Budukh AM; Rajkumar R
    Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effective policies for cervical cancer screening. An international review.
    Fahs MC; Plichta SB; Mandelblatt JS
    Pharmacoeconomics; 1996 Mar; 9(3):211-30. PubMed ID: 10160098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV testing for cervical cancer screening in Croatia.
    Grce M; Grahovac B; Rukavina T; Vrdoljak-Mozetic D; Glavas-Obrovac L; Kaliterna V; Zele-Starcević L
    Coll Antropol; 2007 Apr; 31 Suppl 2():67-71. PubMed ID: 17598507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunistic cervical screening at a sexual health clinic.
    Treacy A; Lyons F; Mulcahy F
    Ir Med J; 2006; 99(7):198-9. PubMed ID: 16986561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Problems of cervical cancer screening programmes.
    Rang EH; Tod ED
    J R Coll Gen Pract; 1988 Jun; 38(311):267-9. PubMed ID: 3255814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent coverage, frequency and costs of organised and opportunistic Pap testing in Finland.
    Salo H; Nieminen P; Kilpi T; Auranen K; Leino T; Vänskä S; Tiihonen P; Lehtinen M; Anttila A
    Int J Cancer; 2014 Jul; 135(1):204-13. PubMed ID: 24347441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the evidence for organised cancer screening programmes.
    Madlensky L; Goel V; Polzer J; Ashbury FD
    Eur J Cancer; 2003 Aug; 39(12):1648-53. PubMed ID: 12888358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytological screening for cervical cancer prevention.
    Denny L
    Best Pract Res Clin Obstet Gynaecol; 2012 Apr; 26(2):189-96. PubMed ID: 22071306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficiency of organised and opportunistic cytological screening for cancer in situ of the cervix.
    Gustafsson L; Sparén P; Gustafsson M; Wilander E; Bergström R; Adami HO
    Br J Cancer; 1995 Aug; 72(2):498-505. PubMed ID: 7640239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mass screening for cervical cancer. A one-year registration of cervical cytological tests].
    Bjørge T; Gunbjørud AB; Langmark F; Skare GB; Thoresen SO
    Tidsskr Nor Laegeforen; 1994 Jan; 114(3):341-5. PubMed ID: 8191435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer screening in France.
    Schaffer P; Sancho-Garnier H; Fender M; Dellenbach P; Carbillet JP; Monnet E; Gauthier GP; Garnier A
    Eur J Cancer; 2000 Nov; 36(17):2215-20. PubMed ID: 11072207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in starting organised screening programmes for cervical cancer in the new member states of the European Union.
    Nicula FA; Anttila A; Neamtiu L; Zakelj MP; Tachezy R; Chil A; Grce M; Kesić V
    Eur J Cancer; 2009 Oct; 45(15):2679-84. PubMed ID: 19699083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of socio-economic variables in cancer screening participation: a comparison between population-based and opportunistic screening in the EU-15.
    Walsh B; Silles M; O'Neill C
    Health Policy; 2011 Aug; 101(3):269-76. PubMed ID: 21420755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mass screening for cervical cancer. Experiences after 25 years of voluntary screening and 2 years of organized screening].
    Thoresen SO; Skare GB; Sandvin O
    Tidsskr Nor Laegeforen; 1997 Aug; 117(18):2613-5. PubMed ID: 9324815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.